U.S. flag

An official website of the United States government

NM_016122.3(CEP83):c.1451C>A (p.Ser484Ter) AND Nephronophthisis 18

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 23, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001925052.4

Allele description [Variation Report for NM_016122.3(CEP83):c.1451C>A (p.Ser484Ter)]

NM_016122.3(CEP83):c.1451C>A (p.Ser484Ter)

Gene:
CEP83:centrosomal protein 83 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q22
Genomic location:
Preferred name:
NM_016122.3(CEP83):c.1451C>A (p.Ser484Ter)
HGVS:
  • NC_000012.12:g.94333608G>T
  • NG_051825.1:g.131381C>A
  • NM_001042399.2:c.1451C>A
  • NM_001346457.2:c.1451C>A
  • NM_001346458.2:c.1139C>A
  • NM_001346459.2:c.1139C>A
  • NM_001368037.1:c.1451C>A
  • NM_001368038.1:c.1451C>A
  • NM_001368039.1:c.1139C>A
  • NM_001368040.1:c.1139C>A
  • NM_001368041.1:c.1226C>A
  • NM_016122.3:c.1451C>AMANE SELECT
  • NP_001035858.1:p.Ser484Ter
  • NP_001333386.1:p.Ser484Ter
  • NP_001333387.1:p.Ser380Ter
  • NP_001333388.1:p.Ser380Ter
  • NP_001354966.1:p.Ser484Ter
  • NP_001354967.1:p.Ser484Ter
  • NP_001354968.1:p.Ser380Ter
  • NP_001354969.1:p.Ser380Ter
  • NP_001354970.1:p.Ser409Ter
  • NP_057206.2:p.Ser484Ter
  • NC_000012.11:g.94727384G>T
  • NR_160431.1:n.1175C>A
  • NR_160432.1:n.2196C>A
Protein change:
S380*
Links:
dbSNP: rs777412559
NCBI 1000 Genomes Browser:
rs777412559
Molecular consequence:
  • NR_160431.1:n.1175C>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_160432.1:n.2196C>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_001042399.2:c.1451C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001346457.2:c.1451C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001346458.2:c.1139C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001346459.2:c.1139C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001368037.1:c.1451C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001368038.1:c.1451C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001368039.1:c.1139C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001368040.1:c.1139C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001368041.1:c.1226C>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_016122.3:c.1451C>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Nephronophthisis 18 (NPHP18)
Identifiers:
MONDO: MONDO:0014374; MedGen: C3890591; Orphanet: 655; OMIM: 615862

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002169772Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 23, 2021)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

CCDC41 is required for ciliary vesicle docking to the mother centriole.

Joo K, Kim CG, Lee MS, Moon HY, Lee SH, Kim MJ, Kweon HS, Park WY, Kim CH, Gleeson JG, Kim J.

Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):5987-92. doi: 10.1073/pnas.1220927110. Epub 2013 Mar 25.

PubMed [citation]
PMID:
23530209
PMCID:
PMC3625310

Mutations of CEP83 cause infantile nephronophthisis and intellectual disability.

Failler M, Gee HY, Krug P, Joo K, Halbritter J, Belkacem L, Filhol E, Porath JD, Braun DA, Schueler M, Frigo A, Alibeu O, Masson C, Brochard K, Hurault de Ligny B, Novo R, Pietrement C, Kayserili H, Salomon R, Gubler MC, Otto EA, Antignac C, et al.

Am J Hum Genet. 2014 Jun 5;94(6):905-14. doi: 10.1016/j.ajhg.2014.05.002. Epub 2014 May 29.

PubMed [citation]
PMID:
24882706
PMCID:
PMC4121475
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002169772.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with CEP83-related conditions. This variant is present in population databases (rs777412559, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Ser484*) in the CEP83 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP83 are known to be pathogenic (PMID: 23530209, 24882706).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024